Paula M O'Shea1, Graham Robert Lee2, Tomás P Griffin3, Vincent Tormey4, Amjad Hayat5, Seán J Costelloe6, Damian Gerard Griffin7, Saradha Srinivasan8, Maurice O'Kane9, Conor M Burke10, John Faul10, Christopher J Thompson11, Gerard Curley12, William P Tormey8. 1. Department of Clinical Biochemistry, Saolta University Health Care Group (SUHCG), Galway University Hospitals, Newcastle Road, Galway, Ireland. PaulaM.OShea@hse.ie. 2. Department of Clinical Biochemistry and Diagnostic Endocrinology, Mater Misericordiae University Hospital, Dublin, Ireland. 3. Centre for Diabetes and Metabolism, SUHCG, Galway University Hospitals, Galway, Ireland. 4. Department of Immunology, SUHCG, Galway University Hospitals, Galway, Ireland. 5. Department of Haematology, University Hospital Galway, Galway, Ireland. 6. Department of Clinical Biochemistry, Cork University Hospital, Cork, Ireland. 7. Department of Clinical Biochemistry, Saolta University Health Care Group (SUHCG), Galway University Hospitals, Newcastle Road, Galway, Ireland. 8. Department of Chemical Pathology, Beaumont Hospital, Dublin 9, Ireland. 9. Department of Clinical Chemistry, Altnagelvin Hospital, Derry, Northern Ireland. 10. Department of Respiratory Medicine, Connolly Hospital Blanchardstown, Dublin 15, Ireland. 11. Department of Endocrinology, Beaumont Hospital, Dublin 9, Ireland. 12. Department of Anaesthesia and Critical Care, Royal College of Surgeons, Dublin, Ireland.
Abstract
INTRODUCTION: Coronavirus disease 2019 (COVID-19), is a respiratory illness caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The Clinical Blood Sciences Laboratory (CBSL) plays a key role in supporting the monitoring and management of patients with COVID-19 disease. OBJECTIVE: To provide a comprehensive CBSL testing protocol to support the medical management of SARS-CoV-2 infection. METHODS: Description of the biochemical, haematological and immunological tests that have a role in the assessment and monitoring of patients with COVID-19 infection. RESULTS: We provide a test menu for clinical laboratories to ensure the effective monitoring, management and prognostication of COVID-19 patients in hospital. CONCLUSION: Given the rapidity with which patients with COVID-19 disease can deteriorate, we recommend regular testing with vigilance paid to the rate and trajectory of change in each of these parameters.
INTRODUCTION: Coronavirus disease 2019 (COVID-19), is a respiratory illness caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The Clinical Blood Sciences Laboratory (CBSL) plays a key role in supporting the monitoring and management of patients with COVID-19 disease. OBJECTIVE: To provide a comprehensive CBSL testing protocol to support the medical management of SARS-CoV-2 infection. METHODS: Description of the biochemical, haematological and immunological tests that have a role in the assessment and monitoring of patients with COVID-19 infection. RESULTS: We provide a test menu for clinical laboratories to ensure the effective monitoring, management and prognostication of COVID-19 patients in hospital. CONCLUSION: Given the rapidity with which patients with COVID-19 disease can deteriorate, we recommend regular testing with vigilance paid to the rate and trajectory of change in each of these parameters.
Entities:
Keywords:
Blood science testing; COVID-19; Hospital laboratories; Monitoring and management
Authors: Ann Leonard; Brian Murray; Anna Rose Prior; Rama Srinivasan; Anne Kane; Gerard Boran Journal: Ir J Med Sci Date: 2021-03-04 Impact factor: 1.568
Authors: Cihan Atila; Clara O Sailer; Stefano Bassetti; Sarah Tschudin-Sutter; Roland Bingisser; Martin Siegemund; Stefan Osswald; Katharina Rentsch; Marco Rueegg; Sabrina Schaerli; Gabriela M Kuster; Raphael Twerenbold; Mirjam Christ-Crain Journal: Eur J Endocrinol Date: 2021-03 Impact factor: 6.558